Results 41 to 50 of about 13,398 (133)

Post-Measles-Mumps-Rubella Vaccination Optic Perineuritis

Neuro-Ophthalmology
Optic perineuritis (OPN) is a rare inflammatory disease affecting the optic nerve sheath, and typically manifesting with varying degrees of vision loss and pain on eye movement. We report a case of a 70-year-old White male who presented to the Houston Methodist Hospital after two episodes of self-resolving acute painless vision loss in the right eye ...
Beqiri, Sara, Abdelsalam, Dina, Ibrahim, Safa, Lee, Andrew G.   +3 more
openaire   +1 more source

Immunogenicity and safety of an inactivated enterovirus 71 vaccine co-administered with measles-mumps-rubella vaccine and live-attenuated Japanese encephalitis vaccine: a phase 4, single-center, randomized controlled trial. [PDF]

Hum Vaccin Immunother, 2021
Liu X, Yang W, Zhang C, Wu H, Wang R, Ding Q, Hu Y, Xiong Y, Zhang S, Wang L.   +9 more
europepmc   +1 more source

Measles, mumps, rubella (MMR) vaccine

Ceylon Medical Journal, 2011
openaire   +3 more sources

Meningoencephalitis after measles-mumps-rubella vaccine. [PDF]

Archives of Disease in Childhood, 1991
M E Ramsay, M Rao
openaire   +1 more source

Comparative Immunogenicity and Safety of Measles-Mumps-Rubella Vaccine When Administered Using Needle Free Injection System to That with Conventional Needle-Syringe in India: A Randomized, Parallel Group Study. [PDF]

Med Devices (Auckl)
Ratta BS, Naik A, Mutha S.
europepmc   +1 more source

A Comparative Prospective Study to Assess Efficacy of Intralesional MMR (Measles, Mumps, Rubella) Vaccine and Intralesional Vitamin D3 in Treatment of Nongenital Warts. [PDF]

Health Sci Rep
Baaniya B, Marahatta S, Dahal R, Shah N.
europepmc   +1 more source

Associations between markers of cellular and humoral immunity to rubella virus following a third dose of measles-mumps-rubella vaccine. [PDF]

Vaccine, 2020
Crooke SN, Ovsyannikova IG, Kennedy RB, Warner ND, Poland GA.   +4 more
europepmc   +1 more source

Immunogenicity and safety of measles-mumps-rubella vaccine delivered by the aerosol, intradermal and intramuscular routes in previously vaccinated young adults: a randomized controlled trial protocol. [PDF]

PLoS One
Saha S, Millier M, Samaranayaka A, Edmonds L, Best E, Ussher J, Anglemyer A, Lee J, Tatley M, Cutts F, van Binnendijk R, McIntyre P.   +11 more
europepmc   +1 more source

Dynamics of the Antibody Response After a Third Dose of Measles-Mumps-Rubella Vaccine Indicate a Slower Decline Compared With a Second Dose. [PDF]

Open Forum Infect Dis, 2020
Kaaijk P, Nicolaie MA, van Rooijen D, van Houten MA, van der Klis FR, Buisman AM, van Binnendijk RS.   +6 more
europepmc   +1 more source

Measles-mumps-rubella vaccine at 6 months of age, immunology, and childhood morbidity in a high-income setting: study protocol for a randomized controlled trial. [PDF]

Trials, 2020
Vittrup DM, Laursen ACL, Malon M, Soerensen JK, Hjort J, Buus S, Svensson J, Stensballe LG.   +7 more
europepmc   +1 more source